Prosecution Insights
Last updated: April 19, 2026

Neotx Therapeutics Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18166938 METHODS AND COMPOSITIONS FOR ENHANCING THE POTENCY OF SUPERANTIGEN MEDIATED CANCER IMMUNOTHERAPY BRISTOL, LYNN ANNE 1643 Final Rejection Feb 09, 2023
17909212 METHODS AND COMPOSITIONS FOR TREATING CANCER WITH IMMUNE CELLS BEHARRY, ZANNA MARIA 1632 Non-Final OA Sep 02, 2022

Managing Neotx Therapeutics Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month